Literature DB >> 27984712

Mangiferin inhibits mastitis induced by LPS via suppressing NF-ĸB and NLRP3 signaling pathways.

Shihui Qu1, Wenqing Wang1, Depeng Li1, Shumin Li1, Like Zhang1, Yunhe Fu2, Naisheng Zhang3.   

Abstract

During the past era, small molecules derived from various plants have attracted extensive attention for their versatile medicinal benefits. Among these, one organic molecule called mangiferin from certain plant species including mangoes and honey bush tea is widely used in treating inflammation. In this study, a LPS-induced mastitis model in mouse is established to investigate the anti-inflammatory effects and mechanism of mangiferin. The result shows that mangiferin significantly alleviates LPS-induced histopathology, meanwhile, also decreases LPS-induced MPO activity. Furthermore, mangiferin treatment remarkably impeded the expression of pro-inflammatory cytokines TNF-α, IL-1β, and IL-6. In addition, mangiferin was found to inhibit LPS-induced NF-ĸB and NLRP3 inflammasome activation. In conclusion, these results suggested that LPS-induced mastitis can be abated by mangiferin through inhibiting NF-ĸB and NLRP3 signaling pathways.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  LPS; Mangiferin; Mastitis; NLRP3

Mesh:

Substances:

Year:  2016        PMID: 27984712     DOI: 10.1016/j.intimp.2016.11.036

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  9 in total

1.  Hederacoside-C Inhibition of Staphylococcus aureus-Induced Mastitis via TLR2 & TLR4 and Their Downstream Signaling NF-κB and MAPKs Pathways In Vivo and In Vitro.

Authors:  Muhammad Akhtar; Aftab Shaukat; Arshad Zahoor; Yu Chen; Ying Wang; Mei Yang; Talha Umar; Mengyao Guo; Ganzhen Deng
Journal:  Inflammation       Date:  2020-04       Impact factor: 4.092

2.  Integrated strategy of network analysis prediction and experimental validation to elucidate the possible mechanism of compound Turkish gall ointment in treating eczema.

Authors:  Xuan Ma; Meng Hao; Ming Hui Zhang; Ya Zeng; Qing Qing Yang; Lu Zhao; Chen Yang Fan; Zhi Hong Ji; Ke Ao Li; Zhi Jian Li; Mirzat Maimaiti; Ji Hong Nie
Journal:  Chin Med       Date:  2022-07-30       Impact factor: 4.546

3.  Mangiferin Alleviates Postpartum Depression-Like Behaviors by Inhibiting MAPK Signaling in Microglia.

Authors:  Meichen Yan; Xuena Bo; Xinchao Zhang; Jingdan Zhang; Yajin Liao; Haiyan Zhang; Yong Cheng; Junxia Guo; Jinbo Cheng
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

4.  CYP1A1 Relieves Lipopolysaccharide-Induced Inflammatory Responses in Bovine Mammary Epithelial Cells.

Authors:  Wen-Yao Zhang; Hao Wang; Shaopei Qi; Xixi Wang; Xueru Li; Kun Zhou; Yong Zhang; Ming-Qing Gao
Journal:  Mediators Inflamm       Date:  2018-02-28       Impact factor: 4.711

5.  Anti-Inflammation and Anti-Pyroptosis Activities of Mangiferin via Suppressing NF-κB/NLRP3/GSDMD Signaling Cascades.

Authors:  Min Feng; Shaoqiang Wei; Shidong Zhang; Ying Yang
Journal:  Int J Mol Sci       Date:  2022-09-04       Impact factor: 6.208

6.  Network Pharmacology and Experimental Validation to Explore the Mechanism of Qing-Jin-Hua-Tan-Decoction Against Acute Lung Injury.

Authors:  Shunli Xiao; Lu Liu; Zhengxiao Sun; Xiaoqian Liu; Jing Xu; Zhongyuan Guo; Xiaojie Yin; Fulong Liao; Jun Xu; Yun You; Tiejun Zhang
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

7.  Peiminine Protects against Lipopolysaccharide-Induced Mastitis by Inhibiting the AKT/NF-κB, ERK1/2 and p38 Signaling Pathways.

Authors:  Qian Gong; Yanwei Li; He Ma; Wenjin Guo; Xingchi Kan; Dianwen Xu; Juxiong Liu; Shoupeng Fu
Journal:  Int J Mol Sci       Date:  2018-09-06       Impact factor: 5.923

8.  LncRNA XIST mediates bovine mammary epithelial cell inflammatory response via NF-κB/NLRP3 inflammasome pathway.

Authors:  Mengru Ma; Yifei Pei; Xixi Wang; Jiaxin Feng; Yong Zhang; Ming-Qing Gao
Journal:  Cell Prolif       Date:  2018-10-25       Impact factor: 6.831

9.  Mangiferin Relieves Lipopolysaccharide-Induced Injury by Up-Regulating miR-181a via Targeting PTEN in ATDC5 Cells.

Authors:  Yunfei Ma; Ying Liu; Yunyan Ma; Nan Jiang; Lei Wang; Bowei Wang; Wanting Niu; Yanjun Hu; Qingrong Lin; Bin Yu
Journal:  Front Pharmacol       Date:  2020-03-05       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.